Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19
Stock Information for Algernon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.